Sign In
Buy AGLE
$12.01
+0 (+0%)
At Close: Feb 26, 2024
Geron (GERN) Gets a Buy Rating from Needham - Markets
06:37pm, Wednesday, 17'th Jun 2020
In a report released today, Chad Messer from Needham reiterated a Buy rating on Geron (GERN – Research Report), with
Analysts' Top Healthcare Picks: Albireo Pharma (ALBO), Monopar Therapeutics Inc (MNPR) - Markets
05:58pm, Tuesday, 16'th Jun 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Albireo Pharma
Aeglea Bio Therapeutics (NASDAQ:AGLE) Trading Up 10.5%
04:00am, Sunday, 14'th Jun 2020
Aeglea Bio Therapeutics Inc (NASDAQ:AGLE)’s stock price was up 10.5% during trading on Friday . The stock traded as high as $8.40 and last traded at $8.39, approximately 270,264 shares changed hands
Selecta Biosciences (SELB) Receives a Buy from Needham - Markets
03:49pm, Friday, 12'th Jun 2020
Needham analyst Chad Messer reiterated a Buy rating on Selecta Biosciences (SELB – Research Report) today and set a price
Analysts' Top Healthcare Picks: Regeneron (REGN), IMARA (IMRA) - Markets
03:44pm, Friday, 12'th Jun 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Regeneron (REGN
Has Aeglea BioTherapeutics (AGLE) Outpaced Other Medical Stocks This Year?
03:30pm, Wednesday, 10'th Jun 2020
Is (AGLE) Outperforming Other Medical Stocks This Year?
Why Aeglea BioTherapeutics (AGLE) Stock Might be a Great Pick
01:03pm, Monday, 08'th Jun 2020
Aeglea BioTherapeutics (AGLE) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Zacks.com featured highlights include: Aeglea BioTherapeutics and Passage Bio
03:17pm, Thursday, 04'th Jun 2020
Zacks.com featured highlights include: Aeglea BioTherapeutics and Passage Bio
Aeglea BioTherapeutics to Present at BIO Digital 2020
08:05pm, Monday, 01'st Jun 2020
AUSTIN, Texas, June 01, 2020 -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as.
Aeglea BioTherapeutics' Shares March Higher, Can It Continue?
03:49pm, Friday, 29'th May 2020
As of late, it has definitely been a great time to be an investor in Aeglea BioTherapeutics
Aeglea BioTherapeutics Announces Change of Location of Annual Meeting of Stockholders to Be Held June 8, 2020
08:10pm, Thursday, 28'th May 2020
Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare and other high-burden diseases, to
The Daily Biotech Pulse: PhaseBio To Start Potential Pivotal COVID-19 Trial, Immunomedics CEO Quits, Tetraphase Receives Sweetened Offer
12:00am, Thursday, 28'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 27)
ADC Therapeutics SA (NYSE:...
Menlo Therapeutics (MNLO) Catches Eye: Stock Jumps 7.1%
12:43pm, Wednesday, 27'th May 2020
Menlo Therapeutics (MNLO) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare and other high-burden diseases, to
Is Aeglea BioTherapeutics (AGLE) Outperforming Other Medical Stocks This Year?
03:30pm, Thursday, 21'st May 2020
Is (AGLE) Outperforming Other Medical Stocks This Year?
